MultiPlan, a key player in the healthcare payment process, stands accused of exacerbating patient costs while benefiting health insurers, as reported by The New York Times.
Travis Dalton, MultiPlan's CEO, acknowledged during a recent earnings call that heightened media scrutiny is challenging the company's operations as it faces declining revenues.
CreditSights speculated that clients may be distancing themselves from MultiPlan due to intensified scrutiny over its controversial business practices, following a damaging exposé.
The New York Times' investigation highlights that MultiPlan's aggressive pricing strategies can leave medical providers with reduced payouts while driving up costs for patients.
[
Collection
]
[
|
...
]